HIV surveillance among sexually transmitted disease clinic attenders in Amsterdam, 1991-1996

AIDS

Volumn 12, Issue 8, 1998, Pages 931-938

  Fennema, Johan S A ^a   Van Ameijden, Erik J C ^a   Coutinho, Roel A ^a   Van Doornum, Gerard J J ^a   Cairo, Irina ^a   Van Den Hoek, Anneke ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

HIV; Sexually transmitted disease clinic; Surveillance; Trends

Indexed keywords

ADULT; ARTICLE; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE;

ADULT; AIDS SERODIAGNOSIS; AMBULATORY CARE FACILITIES; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HOMOSEXUALITY, MALE; HUMANS; MALE; NETHERLANDS; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0032574909     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199808000-00016     Document Type: Article

References (31)

1. The European Study Group: European Community Concerted Action on HIV seroprevalence among sexually transmitted disease patients in 18 European sentinel networks. AIDS 1993, 7:393-400.
2. Kassler WJ, Zenilman JM, Erickson B, Fox R, Peterman TA, Hook III EW: Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994, 8:351-355.
3. McCray E, Oronato IM, the Field Service Branch: Sentinel surveillance of human immunodeficiency virus infection in sexually transmitted disease clinics in the United States. Sex Transm Dis 1992, 19:235-241.
4. Oronato IM, McCray E, Pappaioanou M, et al.: HIV seroprevalence surveys in sexually transmitted disease clinics. Public Health Reports 1990, 105:119-124.
5. Anon: Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990-92. Commun Dis Rep CDR Rev 1993, 3(1)R1-R11.
6. Day NE for the Expert Group: The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994. Commun Dis Report 1996, 6:R1-R24.
7. Peterman TA, Zaidi AA, Wroten J: Decreasing prevalence hides a high HIV incidence: Miami. AIDS 1995, 9:965-970.
8. Batter V, Matela B, Nsuami M, et al.: High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaïre: estimating incidence from serial seroprevalence data. AIDS 1994, 8:811-817.
9. Weinstock HS, Sidhu J, Gwinn M, Karon J, Peterson LR: Trends in HIV seroprevalence among persons attending sexually transmitted diseases clinics in the United States, 1988-1992. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:514-522.
10. Fennema JSA, van Ameijden EJC, Coutinho RA, et al.: HIV prevalence among clients attending a sexually transmitted diseases clinic in Amsterdam: the potential risk for heterosexual transmission. Genitourin Med 1993, 69:23-28.
11. Fennema JSA, van Ameijden EJC, Coutinho RA, et al.: HIV surveillance op een polikliniek voor seksueel overdraagbare aandoenigen in Amsterdam, 1991-1994: lage en stabiele prevalentie onder heteroseksuele bezoekers. Ned Tijdschr Geneeskd 1995, 139:1595-1598.
12. Fennema JSA, van Ameijden EJC, van den Hoek JAR, et al.: The impact of young and recent onset injection drug users on the HIV epidemic in Amsterdam, 1986-1995. Addiction 1997, 92:1457-1455.
13. Cairo I: Annual Report of the Clinic for Sexually Transmitted Diseases (in Dutch). Amsterdam: Division of Public Health and Environment, Municipal Health Service 1996:9-10.
14. Bindels PJE, Mulder-Folkerts DKF, Schutte MF, et al.: Prevalentie van HIV-antistoffen bij zwangere vrouwen in het Amsterdamse HIV-peilstationonderzoek, 1988-1993. Ned Tijdschr Geneeskd 1995, 139:994-997.
15. Barlow G, Daker-White G, Band B: Assortative sexual mixing in a heterosexual clinic population - a limiting factor in HIV spread. AIDS 1997, 11:1039-1044.
16. Dolcini MM, Catania JA, Choi KH, et al.: Cognitive and emotional assessment of received risk for HIV among unmarried heterosexuals. AIDS Educ Prev 1996, 8:294-307.
17. Catchpole MA, Mercy DE, Nicoll A, et al.: Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. BMJ 1996, 312:539-542.
18. Lavreys L, De Clercq E, Van Hove D: Secondary transmission of HIV by aware seropositives, Lancet 1995, 346:1102-1103.
19. Wasserheit JN: Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992, 19:61-77.
20. Atkins MC, Carlin EM, Emery VC., et al.: Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMI 1996, 313:341-342.
21. Huffman J, Maida M, Royce R, et al.: Effect of urethritis therapy on the concentration of HIV-1 in seminal plasma. XI International Conference on AIDS. Vancouver, July 1996 [abstract MoC903].
22. Laga M, Diallo MO, Buvé A: Inter-relationship of sexually transmitted diseases and HIV: where are we now? AIDS 1994: 8 (suppl 1):S119-S124.
23. Grosskurth H, Mosha F, Todd J et al.: Impact of improved treatment of sexually tranmitted diseases on HIV infection in rural Tanzania: randomised controlled trial, Lancet 1995, 346:530-536.
24. Simon PA, Weber M, Ford WL, Cheng F, Kerndt PR: Reasons for HIV antibody test refusal in a heterosexual sexually transmitted disease clinic population. AIDS 1996, 10:1549-1553.
25. Bindels PJE, van den Hoek JAR, Leenvaar-Kuijpers A, et al.: Het waarschuwen van huidige en vroegere seksuele partners van met HIV geïnfecteerde personen: is de tijd er rijp voor? Ned Tijdschr Geneeskd 1992, 136:933-937.
26. Hooykaas C, van der Velde FW, van der Linden MMD, et al.: The importance of ethnicity as a risk factor for STD and heterosexual behavior among heterosexuals. Genitourin Med 1991, 67:378-383.
27. van den Hoek JAR, Coutinho RA: Seksueel overdraagbare aandoeningen, HIV en AIDS bij migranten. Ned Tijdschr Geneeskd 1994, 138:2188-2192.
28. Schwarcz SK, Bolan GA, Kellogg TA, et al.: Comparison of voluntary and blinded HIV type 1 seroprevalence surveys in a high prevalence sexually transmitted disease clinic population. Am J Epidemiol 1993, 137:600-608.
29. Groseclose SL, Erickson B, Quinn TC, et al.: Characterization of patients accepting and refusing routine voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis 1994, 21:31-35.
30. Lones JL, Hutto P, Meyer P, et al.: HIV seroprevalence and reasons for refusing and accepting HIV testing. Sex Transm Dis 1993, 20:334-337.
31. Strickler H, Hoover DR, Dersimonian R: Problems in interpreting HIV sentinel seroprevalence studies. Ann Epidemiol 1995, 5:447-454.